Sandra Vols

Title: Sandra Vols: Innovator in Neutrophil-Targeted Drug Delivery

Introduction

Sandra Vols is a prominent inventor based in Moshav Mata, Israel. She has made significant contributions to the field of medical research, particularly in the development of peptides that target neutrophils. Her innovative work has the potential to enhance drug delivery systems for various medical conditions.

Latest Patents

Sandra Vols holds a patent for neutrophil-binding peptides. This patent discloses peptides that specifically bind to neutrophils and outlines their uses for targeted delivery of drugs or diagnostic agents. These applications are particularly relevant in treating medical conditions such as cancer, as well as infectious, inflammatory, and autoimmune diseases or disorders. She has 1 patent to her name.

Career Highlights

Throughout her career, Sandra has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hadasit Medical Research Services and Development Ltd. Her work in these institutions has allowed her to advance her research and contribute to significant medical innovations.

Collaborations

Sandra has collaborated with esteemed colleagues, including Zvika Granot and Zvi Gregorio Fridlender. These partnerships have further enriched her research and development efforts in the field of medical science.

Conclusion

Sandra Vols is a trailblazer in the realm of neutrophil-targeted drug delivery, with her innovative peptides paving the way for advancements in medical treatments. Her contributions to the field are invaluable and continue to inspire future research.